Joep de Mönnink

"Through my previous work, I gained affinity with gynaecological health care. I built up a network of interesting, valuable and driven people. At the end of 2009, I took the step to realise my dream: to set up a company in which I can contribute to gynaecological care in the Netherlands according to my own ideas, with the aim of making a difference for Dutch women".


Since 2009 Joep is founder and director of Titus Health Care. With the help of a powerful network in gynaecology, extensive knowledge of the Dutch healthcare system and years of experience in the pharmaceutical and biotech industry, Joep contributes to the improvement of gynaecological healthcare in the Netherlands.

Within Titus Health Care Joep mainly focuses on business development and finance. Since 2014, within MedTecht start-up ARTPred, Joep has devoted a lot of attention to the development and marketing of the ReceptIVFity test, the world's first IVF prediction test based on the female microbiome.


Previously, Joep held various marketing, sales and management positions at Serono, Merck KGa and Merck/Serono. Joep was project leader of the integration of Serono into Merck in the Netherlands and was also a member of the global fertility strategy group.